Sereti I - Search Results

1

Interleukin-2 cycling causes transient increases in high-sensitivity C-reactive protein and D-dimer that are not associated with plasma HIV-RNA levels.

Porter BO, Shen J, Kovacs JA, Davey RT, Rehm C, Lozier J, Csako G, Nghiem K, Costello R, Lane HC, Sereti I. Porter BO, et al. Among authors: sereti i. AIDS. 2009 Sep 24;23(15):2015-9. doi: 10.1097/QAD.0b013e32832d72c6. AIDS. 2009. PMID: 19617815 Free PMC article. Clinical Trial.

2

Interleukin 2 leads to dose-dependent expression of the alpha chain of the IL-2 receptor on CD25-negative T lymphocytes in the absence of exogenous antigenic stimulation.

Sereti I, Gea-Banacloche J, Kan MY, Hallahan CW, Lane HC. Sereti I, et al. Clin Immunol. 2000 Dec;97(3):266-76. doi: 10.1006/clim.2000.4929. Clin Immunol. 2000. PMID: 11112366

3

Immunopathogenesis of human immunodeficiency virus: implications for immune-based therapies.

Sereti I, Lane HC. Sereti I, et al. Clin Infect Dis. 2001 Jun 15;32(12):1738-55. doi: 10.1086/320758. Epub 2001 May 16. Clin Infect Dis. 2001. PMID: 11360217 Review.

4

Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy.

Kovacs JA, Vogel S, Metcalf JA, Baseler M, Stevens R, Adelsberger J, Lempicki R, Hengel RL, Sereti I, Lambert L, Dewar RL, Davey RT Jr, Walker RE, Falloon J, Polis MA, Masur H, Lane HC. Kovacs JA, et al. Among authors: sereti i. Eur J Immunol. 2001 May;31(5):1351-60. doi: 10.1002/1521-4141(200105)31:5<1351::AID-IMMU1351>3.0.CO;2-9. Eur J Immunol. 2001. PMID: 11465092 Free article. Clinical Trial.

5

CD4 T cell expansions are associated with increased apoptosis rates of T lymphocytes during IL-2 cycles in HIV infected patients.

Sereti I, Herpin B, Metcalf JA, Stevens R, Baseler MW, Hallahan CW, Kovacs JA, Davey RT, Lane HC. Sereti I, et al. AIDS. 2001 Sep 28;15(14):1765-75. doi: 10.1097/00002030-200109280-00004. AIDS. 2001. PMID: 11579237 Clinical Trial.

6

Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV.

Kovacs JA, Lempicki RA, Sidorov IA, Adelsberger JW, Herpin B, Metcalf JA, Sereti I, Polis MA, Davey RT, Tavel J, Falloon J, Stevens R, Lambert L, Dewar R, Schwartzentruber DJ, Anver MR, Baseler MW, Masur H, Dimitrov DS, Lane HC. Kovacs JA, et al. Among authors: sereti i. J Exp Med. 2001 Dec 17;194(12):1731-41. doi: 10.1084/jem.194.12.1731. J Exp Med. 2001. PMID: 11748275 Free PMC article.

7

Increased peripheral expansion of naive CD4+ T cells in vivo after IL-2 treatment of patients with HIV infection.

Natarajan V, Lempicki RA, Sereti I, Badralmaa Y, Adelsberger JW, Metcalf JA, Prieto DA, Stevens R, Baseler MW, Kovacs JA, Lane HC. Natarajan V, et al. Among authors: sereti i. Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10712-7. doi: 10.1073/pnas.162352399. Epub 2002 Jul 29. Proc Natl Acad Sci U S A. 2002. PMID: 12149467 Free PMC article. Clinical Trial.

8

Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection: characterization of a novel subset of CD4(+)/CD25(+) T cells.

Sereti I, Martinez-Wilson H, Metcalf JA, Baseler MW, Hallahan CW, Hahn B, Hengel RL, Davey RT, Kovacs JA, Lane HC. Sereti I, et al. Blood. 2002 Sep 15;100(6):2159-67. Blood. 2002. PMID: 12200381 Free article.

9

Cutting edge: L-selectin (CD62L) expression distinguishes small resting memory CD4+ T cells that preferentially respond to recall antigen.

Hengel RL, Thaker V, Pavlick MV, Metcalf JA, Dennis G Jr, Yang J, Lempicki RA, Sereti I, Lane HC. Hengel RL, et al. Among authors: sereti i. J Immunol. 2003 Jan 1;170(1):28-32. doi: 10.4049/jimmunol.170.1.28. J Immunol. 2003. PMID: 12496379

10

Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover.

Anthony KB, Yoder C, Metcalf JA, DerSimonian R, Orenstein JM, Stevens RA, Falloon J, Polis MA, Lane HC, Sereti I. Anthony KB, et al. Among authors: sereti i. J Acquir Immune Defic Syndr. 2003 Jun 1;33(2):125-33. doi: 10.1097/00126334-200306010-00002. J Acquir Immune Defic Syndr. 2003. PMID: 12794543

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

251 results

Search Page

Filters